retatrutide 10mg vial reconstitution Dosage: Week-by-Week Chart 2026 Doctor Explains How to Dose

doi: 10.1016/j.ajpc.2024.100679 PMID: 38779187 Vosoughi K et al (2022): Effects of GLP-1 agonists on proportion of weight loss in obesity with or without diabetes: Systematic review and meta-analysis

Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial

If you experience significant side effects, your healthcare provider may delay dose escalation for 2-4 weeks

This is good to help handle common side effects

Kidney Disease: TRANSCEND-CKD Chronic kidney disease (CKD) is a growing comorbidity of obesity and type 2 diabetes

Physicians manage obesity as a chronic disease, not a short-term solution